Q1FY21 results: Cadila Healthcare profit jumps by 50 per cent YoY

Cadila Healthcare Limited, a leading Indian pharmaceutical company announced its quarterly results on August 5, 2020. The company posted a consolidated net profit of Rs 454 crore for Q1FY21, which increased by 49.54 per cent, as compared to Q1FY20 when it reported Rs 303.6 crore.                                                                                                                                                              

The consolidated net sales reported in Q1FY21 came in at Rs 3,639.9 crore, which increased by 4.11 per cent YoY from Rs 3,496.3 crore in Q1FY20. At EBITDA level, the company stood at Rs 815.4 crore in Q1FY21 that increased by 23.79 per cent YoY. For Q1FY20, it posted an EBITDA of Rs 658.7 crore.                                                                                                                                                 

EBITDA margin as of Q1FY21 was at 22.4 per cent that increased by 3.56 per cent YoY. The net profit margin in Q1FY21 came in at 12.47 per cent, which increased by 3.79 per cent YoY. The net profit margin in Q1FY20 was at 8.68 per cent.

At around 1:19 pm, the share is trading down by 1.85  per cent at Rs 394.40 on BSE. The share, today traded on its new 52 week high value of Rs 411.6. It has a 52 week low of Rs 206.45.